A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

P.M. Ambühl, A.C. Tissot, Alma Fulurija, P. Maurer, J. Nussberger, R. Sabat, V. Nief, C. Schellekens, K. Sladko, K. Roubicek, T. Pfister, M. Rettenbacher, H.-D. Volk, F. Wagner, P. Müller, G.T. Jennings, M.F. Bachmann

    Research output: Contribution to journalArticle

    172 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)63-72
    JournalJournal of Hypertension
    Issue number1
    Publication statusPublished - 2007

    Cite this